Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
AI Summary
Internet searches related to weight-loss drugs, specifically GLP-1 receptor agonists, have surged 25-fold since their launch, according to research presented at the International Congress on Obesity held in Mexico City by the World Obesity Federation. This indicates a significant rise in public interest in obesity treatment.
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World Obesity Federation (July 15β17) shows.